Healthcare systems aren’t making the most of biosimilars: pharma needs to support themBiosimilars could save European and US healthcare systems billions – but more needs to be done to maximise Share XHealthcare systems aren’t making the most of biosimilars: pharma needs to support themhttps://pharmaphorum.com/views-and-analysis/healthcare-systems-aren-t-making-the-most-of-biosimilars-pharma-needs-to-support-them/
Sandoz bags first-ever biosimilar approval in USNovartis generics subsidiary Sandoz made history ahead of the weekend after getting approval in the US for Zarxio, Share XSandoz bags first-ever biosimilar approval in UShttps://pharmaphorum.com/news/sandoz-bags-first-ever-biosimilar-approval-in-us/
